Why the study?
Does intravenous administration of regular insulin alter serum dopamine-beta-hydroxylase (DBH) activity in healthy young male and female volunteers?
Does intravenous administration of regular insulin alter serum dopamine-beta-hydroxylase (DBH) activity in healthy young male and female volunteers?
Serum DBH activity does not significantly change during insulin-induced hypoglycemia, questioning its utility as a marker for adrenomedullary function.
Answers are grounded in this paper and cite their sources.
Serum DBH unchanged during insulin hypoglycemia; leaves open its utility as an adrenomedullary marker and requires validation in larger cohorts.
The relationship between serum dopamine-beta-hydroxylase (DBH) activity and sympathetic nervous system activation in response to insulin-induced hypoglycemia was investigated in healthy young male and female volunteers. Serum DBH activity and glucose levels were measured in blood samples obtained 30 min before and 90 min after the iv administration of regular insulin or placebo. All subjects developed significant hypoglycemia in response to the insulin and manifested signs of sympathetic activation, including increased heart rate, diaphoresis, and lightheadedness. However, despite obvious clinical manifestations of increased sympathetic activity, none of the subjects exhibited a significant alteration in serum DBH activity either in comparison to baseline or placebo values. These data question the suitability of serum DBH measurements for assessing adrenomedullary function in man.
No takes yet. Share an insight, caveat, or question.
NISULA et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: